Precision Cancer Classification and Biomarker Identification from mRNA Gene Expression via Dimensionality Reduction and Explainable AI

Efficiency gains enable practical clinical application: The research demonstrates that cancer classification can achieve 96.61% accuracy using only 500 genes instead of analyzing all 19,238 available genes, suggesting that streamlined analysis could make genetic testing faster and more cost-effective for patients.

Explainability is essential for medical AI: The authors specifically employed Explainable AI techniques alongside their classification model, recognizing that doctors and patients need to understand why a cancer diagnosis was made—not just accept an algorithm's prediction—which is critical for building trust in AI-assisted medical decisions.

Personalized medicine becomes more feasible: By identifying cancer-specific gene signatures for 33 distinct cancer types, this approach supports the shift toward tailored treatment plans based on individual tumor characteristics rather than one-size-fits-all therapies, potentially improving patient outcomes.

Responsible AI requires validation of biological meaning: The research goes beyond achieving high accuracy by using Differential Gene Expression analysis to verify that identified genes have genuine biological significance, demonstrating that responsible AI development in healthcare must validate that algorithmic findings align with actual medical science.

Dimensionality reduction balances performance with interpretability: By successfully reducing the dataset from nearly 20,000 features to 500 while maintaining accuracy, the work illustrates how responsible AI can make complex medical systems more transparent and manageable without sacrificing reliability.